Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer with particularly poor survival rates for patients. Targeted molecular therapies are lacking, and current treatment is generally limited to surgical resection or liver transplantation. Overexpression and aberrant signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Xian, Lu, Qian, Wang, Gang, Huang, Wei, Yang, Linlin, Chen, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103654/
https://www.ncbi.nlm.nih.gov/pubmed/30154664
http://dx.doi.org/10.2147/OTT.S160638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103654/
https://www.ncbi.nlm.nih.gov/pubmed/30154664
http://dx.doi.org/10.2147/OTT.S160638

Ejemplares similares